Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Blume-Jensen Peter sold 14,036 Acrivon Therapeutics, Inc. shares (Form 4)
Traded Aug 25, 2026 · Filed Aug 27, 2026
On Aug 25, 2026, Blume-Jensen Peter (Director, President and CEO) sold 14,036 Acrivon Therapeutics, Inc. shares at US$2.21 for US$31,020, leaving 2,230,052 shares. Filed Aug 27, 2026 (Form 4).
- Sold
- 14,036 shares
- Price
- US$2.21
- Value
- US$31,020
- Holding after
- 2,230,052 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Common Stock | Sale | 14,036 | US$2.21 | 2,230,052 | Direct |
Source
Related
- Acrivon Therapeutics, Inc.
- Blume-Jensen Peter
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Blume-Jensen Peter · May 20, 2026
- Form 4 · Blume-Jensen Peter · May 18, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Miller Mary · Aug 20, 2026
- Form 4 · Gamelin Erick · Aug 20, 2026